Direct Epidemio-Statistics — Expert office in epidemiostatistics and risk
We help SMEs and innovative companies leverage precise data, model and score risks, anticipate adverse events, and create value-driven services.
Nov 26, 2025Following up with railway infrastructure stakeholders and engaging with new counterparts.
Nov 20, 2025Tracking the latest developments of our cloud provider through OVHcloud/AMD technical sessions, including updates on 3-AZ.
Nov 19, 2025Discovering the sector and engaging with several stakeholders in homeland security, safety, and defense.
Nov 19-20, 2025Re-engaging with last year’s contacts and continuing discussions with current counterparts ahead of upcoming demonstrations.
Nov 18, 2025Presenting our work to logistics stakeholders, notably insurers and transport companies, and listening to their impressions.
Nov 5, 2025An opportunity to take a 360° view of public transport, connect with new stakeholders, and follow up on earlier discussions.
Nov 4, 2025Listening to the CEOs of Stellantis, Renault, Valeo and Mercedes-Benz, along with insights from Roland Lescure and Stéphane Séjourné, for a 360° view of Europe’s automotive industry.
Sep 11, 2025Stopping by the ID4Mobility event in Le Mans, an opportunity to connect with them and speak with one of our current counterparts.
Jun 16, 2025An opportunity for a first touchpoint with international public-transport stakeholders and to reconnect with others met earlier.
Apr 2, 2025Attendance, networking and discussions about SAMRoute.
Feb 6, 2025Attendance, networking and discussions about SAMRoute.
Jan 22, 2025Connecting with a few new stakeholders and moving forward on earlier discussions with others.
Nov 28, 2024Attending Octave Klaba’s keynote, stopping by the startup team, and connecting with a few partners from the OVH network.
Nov 20, 2024A first 360° look at the ecosystem of solutions for local governments, initial contacts and early impressions gathered.
Nov 6, 2024First international exhibition in Barcelona to connect with mobility stakeholders and discover international exhibitors in innovative geospatial solutions.
Oct 16, 2024A must-attend trade show to step into the automotive and mobility sectors, meeting several stakeholders and laying the groundwork for future discussions.
Oct 1–4, 2024On-site presence to discuss agrivoltaics.
Nov 12–18, 2023Immersion to understand risks and solutions.
Nov 10, 2023Presentation of the global road risk scoring and Q&A.
Our expertise
What are Direct Epidemio-Statistics' areas of expertise?
Statistical epidemiology
A broad, comprehensive spectrum of statistical methods to:
- characterize, model, and compare your study populations
- improve survival, quality of life, or complication counts
- reduce the number of serious adverse events (SAEs)
- conduct health surveillance.
Excerpts / client case
Quantitative risk
Methods and solutions at every stage of your at-risk case management process, notably to:
- better understand the pathogenesis of your adverse events
- summarize and compare characteristics of studied populations
- improve yields or techno-economic efficiency
- proactively monitor your at-risk cases...
Excerpts / client case
Market access marketing
Argumentation intelligence and techno-scientific marketing to:
- present your studies — methodology, tables, charts
- defend your market access, notably during expert reviews
- produce marketing collateral showcasing your results or products.
Our expert missions
Feasibility studyProtocol designCohort follow-upAnalysis and synthesisMarket access marketingExcerpts / client case
Your benefits
What can Direct Epidemio-Statistics bring you?
Clarified pathogeneses
Expert help to detect precursor or causal factors that contribute to the emergence, development, or maintenance of adverse events (SAEs).
Ambition, results, and performance
To accelerate change and save time, cut direct and ancillary costs, or secure performance with more reliable processes.
More simplicity and efficiency
To reduce overall process complexity, improve compliance with rules or standards, gain autonomy and responsiveness, and enhance operational practicality and comfort.
A lasting, planned, adaptable partnership
Pre-assess techno-economic feasibility; help you anticipate, plan ahead, and broaden perspective; while staying responsive and available to solve punctual challenges.
Advisory, commitment, and trust
A partner who supports you, advises you, respects your approach, and keeps their expertise at your disposal.
The + of Direct Epidemio-Statistics
What makes us specific?
First reason: our advisory expertise
Second reason: our French CIR accreditation (R&D tax credit) granted by the Ministry of Higher Education and Research, which:
- reduces our billed R&D cost by 30% via tax credit;
- is an indicator of our experience, expertise, and professionalism;
- covers the period 2022–2027.
Third reason: our mindset, characterized by:
- innovative choices, no taboos, detached from the status quo;
- punctuality and goal achievement, building reliability and trust;
- neutrality when surveying possible options;
- availability and accessibility.